Your session is about to expire
← Back to Search
RAPIDe-2 Trial Summary
This trial will study the long-term effects of a drug for hereditary angioedema, a condition where people have swellings in different parts of the body.
- Hereditary Angioedema
- C1 Esterase Inhibitor Deficiency
RAPIDe-2 Trial Eligibility Criteria
Inclusion CriteriaYou will be eligible if you check “Yes” for the criteria below
RAPIDe-2 Trial Timeline
Study ObjectivesOutcome measures can provide a clearer picture of what you can expect from a treatment.
Awards & Highlights
RAPIDe-2 Trial Design
Find a Location
Who is running the clinical trial?
- You are taking certain strong medications that can interact with the study drug.You have a heart problem that shows up on an electrocardiogram test.You have another serious health condition that could make it unsafe for you to join the study.You have a history of alcohol or drug abuse, or you currently struggle with substance dependence or abuse.You have been diagnosed with hereditary angioedema (HAE) type I or II.You have used certain medications for a specific condition within a certain time before joining the study.
- Group 1: Part A: Medium dose
- Group 2: Part A: High dose
- Group 3: Part A: Low dose
- Group 4: Part B: Selected dose
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Are new test subjects needed for this experiment?
"This clinical trial is actively looking for patients, with the original posting on July 19th, 2022 and the most recent update on October 25th, 2022."
Who else is applying?
What site did they apply to?
What portion of applicants met pre-screening criteria?
How many prior treatments have patients received?
What questions have other patients asked about this trial?
Why did patients apply to this trial?
Share this study with friends